ASYMCHEM

Asymchem Laboratories (Stock Code: 002821.SZ/6821.HK) is a world-leading CDMO company that provides high-quality, one-stop R&D and manufacturing services for new drugs globally. Committed to accelerating drug approval processes and improving the quality of life, Asymchem leverages continuous technological innovation to offer comprehensive CMC services throughout the drug lifecycle for pharmaceutical and biotechnology companies both in China and internationally, expediting new drug development and application. The company currently operates eight global R&D and production bases, over 20 subsidiaries, and employs more than 9,800 staff. Its business scope spans from early clinical stages to commercialization, including the R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic cooperation and business expansion, Asymchem is progressively building an integrated service ecosystem for innovative drug development, acting as a partner in global new drug R&D and manufacturing.